![Geno Germano](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Geno Germano
Chairman at
ENTERA BIO LTD.
Net worth: 486 491 $ as of 2026-09-29
Profile
Mr. Geno J.
Germano is an Independent Chairman at Entera Bio Ltd. and an Independent Director at Precision BioSciences, Inc. He is on the Board of Directors at Eloxx Pharmaceuticals, Inc., Harmony Biosciences Holdings, Inc. and Precision BioSciences, Inc. Mr. Germano was previously employed as a President, Chief Executive Officer & Director by Elucida Oncology, Inc., an Independent Director by Bioverativ, Inc., a Chairman by SAGE Therapeutics, Inc., a President by Intrexon Corp., a Group President-Global Innovative Pharma Business by Pfizer Inc., a Trustee by Albany College of Pharmacy, a President & General Manager-Specialty Care by Wyeth LLC, a President-US Pharmaceuticals & Women's Health Care by Wyeth Pharmaceuticals LLC, a Member by Group of 50, a Managing Director by Wyeth Australia Pty Ltd., and a Managing Director by Wyeth New Zealand.
He also served on the board at Zoetis, Inc., Biotechnology Innovation Organization and The Medicines Co. He received his undergraduate degree from Albany College of Pharmacy & Health Sciences.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-09-24 | 47,492 ( 0.2% ) | 297 300 $ | 2026-09-29 | |
ENTERA BIO LTD. 0.04% | 2026-09-30 | 65,014 ( 0.04% ) | 189 191 $ | 2026-09-29 |
| 2026-05-13 | 0 ( -.--% ) | - $ | 2026-09-29 | |
| 2026-10-18 | 0 ( -.--% ) | - $ | 2026-09-29 |
Geno Germano active positions
| Companies | Position | Start |
|---|---|---|
| PRECISION BIOSCIENCES, INC. | Director/Board Member | 2020-03-09 |
| ENTERA BIO LTD. | Chairman | 2026-02-03 |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Director/Board Member | 2026-05-13 |
| ELOXX PHARMACEUTICALS, INC. | Director/Board Member | 2026-10-18 |
Former positions of Geno Germano
| Companies | Position | End |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Chairman | 2025-07-30 |
Elucida Oncology, Inc.
 Elucida Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on clinical research and development | Chief Executive Officer | 2024-05-31 |
Albany College of Pharmacy & Health Sciences
 Albany College of Pharmacy & Health Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Director/Board Member | 2017-12-31 |
| PRECIGEN, INC. | President | 2017-03-09 |
| PFIZER INC. | Corporate Officer/Principal | 2016-01-31 |
Education of Geno Germano
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
79
1st degree connections
18
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
Precigen, Inc.
 Precigen, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Precision BioSciences, Inc.
 Precision BioSciences, Inc. BiotechnologyHealth Technology Develops technology to produce custom, genome-editing enzymes for human health and biological research | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Zoetis, Inc.
 Zoetis, Inc. Pharmaceuticals: MajorHealth Technology Develops animal vaccines and prescriptions medicines | Health Technology |
Albany College of Pharmacy & Health Sciences
Albany College of Pharmacy & Health Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Group of 50 | |
Wyeth Australia Pty Ltd. | |
Entera Bio Ltd.
 Entera Bio Ltd. Pharmaceuticals: MajorHealth Technology Manufactures flu medicines | Health Technology |
Wyeth New Zealand | |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
Elucida Oncology, Inc.
Elucida Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on clinical research and development | Health Technology |
Harmony Biosciences Holdings, Inc.
 Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
Eloxx Pharmaceuticals, Inc.
 Eloxx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics to treat cystic fibrosis, inherited retinal disorders and other diseases | Health Technology |
- Stock Market
- Insiders
- Geno Germano
